Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2016042023559N3Phase 2Completed
Phase 2, single-arm trial of furosemide in end-stage kidney disease (ESKD), sponsored by Tabriz University of Medical Sciences. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2016042023559N3.